一遍又一遍 - - 在含有抗真菌剂的尿液中,Candida albicans的存活率
Nevio Facchini1,2, Lukas Wernli1,3, Malte Rieken2,4
1Department of Biomedical Engineering, University of Basel, Hegenheimermattweg 167B/C, 4123 Allschwil, Switzerland.
Pharmaceutics
|May 25, 2024
概括
清真 (Candida albicans) 尿路感染 (UTI) 即使经过抗真菌治疗,也可能复发. 幸存的细胞具有较低的代谢活性,可能导致再生和感染复发.
科学领域:
- 菌类学 菌类学是指菌类学.
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 经常出现的Candida albicans尿路感染 (UTI) 是很常见的.
- 目前使用的抗真菌药物,如可纳,是防真菌的,而不是杀菌的,导致治疗失败.
研究的目的:
- 了解Candida albicans在尿液中的长期生存和代谢活性,在最小抑制度 (MIC) 的抗真菌药物中.
- 为了确定导致Candida尿路感染复发的因素,尽管接受了治疗.
主要方法:
- 使用常规方法和异热微热度计 (IMC) 来监测存活率和代谢活性.
- 测量了Candida albicans的葡萄糖和蛋白质消耗.
- 研究了死去的Candida细胞对活细胞生长的影响.
主要成果:
- 在抗真菌药物的存在下,Candida albicans的生长速度降低 (48-88%) 和延迟阶段增加 (6-172小时).
- 相对于资源耗尽,新陈代谢活动峰值的延迟.
- 死亡的Candida细胞增强了人工尿中的活细胞的生长.
结论:
- 即使在抗真菌治疗期间,Candida albicans的复发也可能发生.
- 幸存细胞的低代谢活性,可能涉及自和胆胞形成,可能会导致复发.
- 了解这些机制对于改善Candida尿路感染治疗至关重要.
相关概念视频
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Urine Studies II: Urine Culture and Sensitivity Test
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


